Anti-IL-17F antibody [EPR17830-169]
- RabMAb
- Recombinant
- What is this?
2
(1 Review)
|
(2 Publications)
Rabbit Recombinant Monoclonal IL-17F antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Mouse samples. Cited in 2 publications.
View Alternative Names
Interleukin-17F, IL-17F, Il17f
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-IL-17F antibody [EPR17830-169] (AB187059)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed 90% methanol-fixed EL4 (mouse lymphoma T lymphocyte) treated with 50ng/ml Phorbol-12-myristate-13-acetate (PMA) and 500ng/ml Ionomycin calcium salt for 24 hours, and 500ng/ml Brefeldin A (BFA) was added for the last 20 hours (Right) / Untreated control (Left) labeling IL17F with ab187059 at 1/60 dilution.
Secondary antibody used Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at a 1/2000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-IL-17F antibody [EPR17830-169] (AB187059)
IL17F was immunoprecipitated from 0.35 mg of EL4 (mouse lymphoma T lymphocyte) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate with ab187059 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab187059 at 1/1,000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/5,000 dilution.
Lane 1 : EL4 (mouse lymphoma T lymphocyte) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate 10 μg (Input).
Lane 2 : EL4 treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500 ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab187059 in EL4 treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500 ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 10 seconds
All lanes:
Immunoprecipitation - Anti-IL-17F antibody [EPR17830-169] (ab187059)
Predicted band size: 18 kDa
false
- WB
Supplier Data
Western blot - Anti-IL-17F antibody [EPR17830-169] (AB187059)
Blocking/Diluting buffer : 5% NFDM/TBST
The molecular mass observed is consistent with the literature (PMID 2212322).
Expression of IL-17F in EL4 cells is increased by PMA and Ionomycin treatment (PMID 28382171).
All lanes:
Western blot - Anti-IL-17F antibody [EPR17830-169] (ab187059) at 1/1000 dilution
Lane 1:
Untreated EL4 (mouse lymphoma T lymphocyte), whole cell lysate at 10 µg
Lane 2:
EL4 treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500 ng/ml Brefeldin A (BFA) was added to the treated cells last 20 hours, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 18 kDa
Observed band size: 16-18 kDa
false
Exposure time: 48s
- WB
Supplier Data
Western blot - Anti-IL-17F antibody [EPR17830-169] (AB187059)
Blocking/Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-IL-17F antibody [EPR17830-169] (ab187059) at 1/5000 dilution
Lane 1:
Mouse IL17A recombinant protein (aa26-158) 10 ng
Lane 2:
Mouse IL17F recombinant protein (aa29-161) 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 18 kDa
Observed band size: 18 kDa
false
Exposure time: 26s
Related conjugates and formulations (3)
-
Anti-IL-17F antibody [EPR17830-169] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-IL-17F antibody [EPR17830-169]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-IL-17F antibody [EPR17830-169]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Journal of thoracic disease 16:6024-6036 PubMed39444871
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:2172-2187 PubMed37293165
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com